Justin Dennie
About Justin Dennie
Justin Dennie is the Director of Oncology Clinical Development at Bristol-Myers Squibb, with extensive experience in oncology clinical development and translational medicine.
Company
Justin Dennie is currently working at Bristol-Myers Squibb as the Director of Oncology Clinical Development. Bristol-Myers Squibb is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative medicines for patients with serious diseases, particularly in areas such as oncology, immunology, and cardiovascular health.
Title
Justin Dennie holds the title of Director, Oncology Clinical Development at Bristol-Myers Squibb. In this role, he is responsible for overseeing the clinical development programs for oncology treatments, guiding the strategy for clinical trials, and ensuring the successful advancement of therapeutic candidates through various stages of clinical testing.
Previous Roles
Prior to his current role at Bristol-Myers Squibb, Justin Dennie worked at several other leading pharmaceutical companies. From 2017 to 2019, he served as Director, Oncology Clinical Development at Advaxis, Inc. in Princeton. Before that, he was the Clinical Lead for Experimental Medicine at Daiichi Sankyo, Inc. from 2014 to 2017. He began his career at Merck, where he worked as a Senior Scientist in Translational Medicine and Clinical Pharmacology from 2011 to 2014, and as a Postdoctoral Fellow from 2009 to 2011.
Education and Expertise
Justin Dennie has a solid educational background in pharmacy and business. He earned his Doctor of Pharmacy (PharmD) degree from Creighton University School of Pharmacy, where he studied from 2003 to 2009. He also achieved a Master of Business Administration (MBA) from Creighton University Heider College of Business, studying from 2006 to 2008. His expertise spans over a decade in oncology clinical development and translational medicine, with experience in both experimental medicine and clinical pharmacology.
Academic and Early Career
In addition to his roles in the pharmaceutical industry, Justin Dennie contributed to academia as an Adjunct Faculty member at Rutgers University, where he was part of the Ernest Mario School of Pharmacy from 2009 to 2011. He also gained early career experience in medical affairs through an internship at sanofi-aventis in 2008.